XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS - Turkey License ae48c7d3bb7063202f2b96792ff66e5a
Access comprehensive regulatory information for XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ae48c7d3bb7063202f2b96792ff66e5a with license number 2022/469and contains active ingredient Denosumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
21,000+ Products
ae48c7d3bb7063202f2b96792ff66e5a
License Details
Turkey SFDA License: ae48c7d3bb7063202f2b96792ff66e5a

